{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T23:25:05Z","timestamp":1781133905177,"version":"3.54.1"},"reference-count":13,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2014,1,27]],"date-time":"2014-01-27T00:00:00Z","timestamp":1390780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2014,2]]},"abstract":"ABSTRACT<\/jats:title>We determined the comparative activity of SMT19969 (SMT) against 162 strains representing 35 well-characterizedClostridium<\/jats:named-content>species in clusters I to XIX and 13Clostridium<\/jats:named-content>species that had no 16S rRNA match. SMT MICs ranged from 0.06 to >512 \u03bcg\/ml and were not species related. SMT might have less impact on normal gut microbiota than otherClostridium difficile<\/jats:named-content>infection (CDI) antimicrobials.<\/jats:p>","DOI":"10.1128\/aac.02184-13","type":"journal-article","created":{"date-parts":[[2013,11,19]],"date-time":"2013-11-19T04:59:32Z","timestamp":1384837172000},"page":"1187-1191","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":26,"title":["ComparativeIn Vitro<\/i>Activities of SMT19969, a New Antimicrobial Agent, against 162 Strains from 35 Less Frequently Recovered Intestinal Clostridium Species: Implications for Clostridium difficile Recurrence"],"prefix":"10.1128","volume":"58","author":[{"given":"Ellie J. C.","family":"Goldstein","sequence":"first","affiliation":[{"name":"R. M. Alden Research Laboratory, Culver City, California, USA"},{"name":"David Geffen School of Medicine at UCLA, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane M.","family":"Citron","sequence":"additional","affiliation":[{"name":"R. M. Alden Research Laboratory, Culver City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerin L.","family":"Tyrrell","sequence":"additional","affiliation":[{"name":"R. M. Alden Research Laboratory, Culver City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051639"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1086\/659156"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1086\/657116"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1086\/519265"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.042010-0"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00845-13"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01443-07"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1099\/00207713-44-4-812"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01136-13"},{"key":"e_1_3_2_11_2","volume-title":"Wadsworth-KTL anaerobic bacteriology manual","author":"Jousimies-Somer HR","year":"2002","unstructured":"Jousimies-SomerHRSummanenPCitronDMBaronEJWexlerHMFinegoldSM. 2002. Wadsworth-KTL anaerobic bacteriology manual. Star Publishing, Belmont, CA."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","DOI":"10.1128\/9781555816728","volume-title":"Manual of clinical microbiology","author":"Versalovic J","year":"2011","unstructured":"VersalovicJCarrolKCFunkeGJorgensenJHLandryMLWarnockDW. 2011. Manual of clinical microbiology. ASM Press, Washington, DC."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2011.04.002"},{"key":"e_1_3_2_14_2","volume-title":"CLSI document M11-A8","author":"Clinical and Laboratory Standards Institute","year":"2012","unstructured":"Clinical and Laboratory Standards Institute. 2012. Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard\u20148th edition. CLSI document M11-A8. CLSI, Wayne, PA."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02184-13","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02184-13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T21:37:33Z","timestamp":1688679453000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.02184-13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["10.1128\/AAC.02184-13"],"URL":"https:\/\/doi.org\/10.1128\/aac.02184-13","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"2013-10-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-11-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-01-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}